助眠产品：科技与全球市场

全球睡眠辅助科技市场预计将从 2025 年的 1,035 亿美元成长到 2030 年的 1,360 亿美元，2025 年至 2030 年的复合年增长率为 5.6%。

预计北美市场将从2025年的440亿美元成长到2030年的591亿美元，2025年至2030年的复合年增长率为6.1%。预计亚太市场将从2025年的215亿美元成长到2030年的301亿美元，2025年至2030年的复合年增长率为6.9%。

本报告考察了全球睡眠辅助技术市场，并提供了市场概况、市场影响因素和市场机会分析、技术趋势、法律制度、市场规模趋势和预测、按各个细分市场和地区进行的详细分析以及主要企业的概况。

目录

第一章执行摘要

• 市场展望
• 调查范围
• 市场概况
• 市场动态与成长要素
• 新兴技术
• 细分市场分析
• 区域分析
• 结论

第二章 市场概览

• 概述
• 目前的研究重点是睡眠
• 美国国立卫生研究院资助睡眠研究
• 睡眠辅助科技市场的波特五力分析
• 宏观经济因素分析
• 睡眠障碍增加和生活方式改变
• 消费者越来越偏好非药物和天然疗法。
• 可支配收入和医疗保健相关消费支出增加
• 美国关税对全球助眠技术市场的影响

第三章 市场动态

• 概述
• 市场驱动因素
• 失眠加剧
• 阻塞型睡眠呼吸中止症（OSA）盛行率上升
• 不健康的生活方式会增加对药品的需求。
• 全球老年人口正在增加。
• 市场限制
• 安全隐忧和产品召回
• 助眠辅助器具高成本
• 市场机会
• 助眠产品创新日益增多
• 对睡眠障碍治疗设备的需求不断增长
• 市场挑战
• 某些地区的认知度和接受度有限
• 整合和互通性问题

第四章：监理现状

• 美国法律规范
• 欧盟法律规范
• 日本的法律规范
• 分类和市场核准
• 上市后监测
• 印度法律规范
• 中国的法律规范

第五章 新兴技术与专利分析

• 重点总结
• 穿戴式睡眠追踪技术
• 睡眠基因组学和药物基因组学
• 人工智慧驱动的睡眠分析
• 神经刺激设备
• 失眠认知行为疗法（CBT-I）
• 专利分析
• 主要发现

第六章 市场区隔分析

• 细分市场分析
• 按产品类型分類的助眠产品市场
• 重点总结
• 床垫和枕头
• 睡眠呼吸中止症治疗设备
• 製药
• 睡眠研究所
• 居家睡眠测试 (HST)
• 以睡眠障碍分類的助眠产品市场
• 重点总结
• 失眠
• 睡眠呼吸中止症
• 不宁腿（RLS）
• 其他的
• 地理细分
• 按地区分類的助眠产品市场
• 重点总结
• 北美洲
• 欧洲
• 亚太地区
• 南美洲
• 中东和非洲

第七章 竞争讯息

• 重点总结
• 产业情景
• 机会：新兴市场
• 主要发展和策略
• 伙伴关係与合作
• 获得
• 业务拓展
• 产品上市及FDA核准

第八章 环境、社会与管治视角

• ESG简介
• 主要製造商的ESG永续性
• BCC 的结论

第九章附录

• 调查方法
• 参考
• 简称
• 公司简介
• ADVANCED BRAIN MONITORING INC.
• ALPHABET INC. (GOOGLE INC.)
• AMBULATORY MONITORING INC.
• AMETRIS LLC.
• APPLE INC.
• APNEA SCIENCES
• BLAIREX LABORATORIES INC.
• CADWELL INDUSTRIES INC.
• CAMNTECH LTD.
• FISHER & PAYKEL HEALTHCARE LTD.
• GSK PLC
• KONINKLIJKE PHILIPS NV
• NIHON KOHDEN CORP.
• RESMED
• SANOFI
• 新兴Start-Ups和市场颠覆者

The global market for sleep aid technologies is estimated to grow from $103.5 billion in 2025 to reach $136 billion by 2030, at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2030.

The North American market for sleep aid technologies is estimated to grow from $44 billion in 2025 to reach $59.1 billion by 2030, at a CAGR of 6.1% from 2025 to 2030.

The Asia-Pacific market for sleep aid technologies is estimated to grow from $21.5 billion in 2025 to reach $30.1 billion by 2030, at a CAGR of 6.9% from 2025 to 2030.

Report Scope

The report provides an overview of the global sleep aid technology market, analyzing key trends, adoption patterns and growth potential. It presents global revenue ($ Million) for the base year 2024, estimated data for 2025, and forecasts through 2030. The market is segmented by product type, end-user industry, sleep disorder and geography. Regional coverage includes North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, with detailed analyses of major countries, such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India.

The report highlights the current and future potential of the sleep aid technology market, providing insights into the competitive environment, regulatory scenario, key drivers, restraints and emerging opportunities. Market shares are detailed by product (mattresses and pillows, sleep apnea devices, medications, sleep laboratories and home sleep tests) and sleep disorder (insomnia, sleep apnea, restless leg syndrome). The study further explores the role of digital and AI-enabled solutions, including wearables, mobile applications, bright bedding and digital therapeutics, in shaping the future of sleep health management.

A comprehensive competitive landscape analysis ranks and evaluates global companies, covering strategic initiatives, R&D investments, partnerships and acquisitions. The report provides company profiles that offer insights into product portfolios and technological strengths, emphasizing innovations in AI, sensors and digital health integration. By combining detailed segmentation, revenue forecasts and strategic analysis, the report provides an overview of the sleep aid technology market, serving as a valuable resource for stakeholders, including healthcare providers, payers, technology developers and investors.

Report Includes

• 49 data tables and 76 additional tables
• An overview of the global market for sleep aids technologies
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimates for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
• Evaluation of the current market size and revenue growth prospects specific to the market, accompanied by a market share analysis by product type, sleep disorder and region
• Analysis of current and future demand in the market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges and opportunities affecting market growth
• Discussion of the role of digital and AI-enabled solutions in shaping the future of sleep health management
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
• Market share analysis of the key market participants, along with their research priorities, product portfolios, global rankings and competitive landscape
• Profiles of the major companies, including Fisher & Paykel Healthcare Ltd., ResMed, Koninklijke Philips N.V., Alphabet Inc. (Google Inc.), and Apple Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Current Research Focused on Sleep
• NIH Funding for Research on Sleep
• Porter's Five Forces Analysis of the Market for Sleep Aid Technology
• Bargaining Power of Suppliers (Moderate)
• Bargaining Power of Buyers (Moderate to High)
• Threat of New Entrants (Moderate)
• Threat of Substitutes (Moderate to High)
• Degree of Competition (Moderate to High)
• Macroeconomic Factors Analysis
• Rising Prevalence of Sleep Disorders and Lifestyle Changes
• Growing Consumer Preference for Nonpharmacological and Natural Solutions
• Rising Disposable Income and Consumer Spending on Wellness
• U.S. Tariffs' Impact on the Global Sleep Aid Technology Market

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Rising Cases of Insomnia Disorders
• Escalating Prevalence of Obstructive Sleep Apnea (OSA)
• Growing Demand for Medication Due to Unhealthy Lifestyles
• Increasing Geriatric Population Worldwide
• Market Restraints
• Safety Concerns and Product Recalls
• High Cost of Sleep Aid Devices
• Market Opportunities
• Growing Number of Sleep Aid Product Innovations
• Growing Demand for Devices to Treat Sleep Disorders
• Market Challenges
• Limited Awareness and Adoption in Certain Regions
• Integration and Interoperability Issues

Chapter 4 Regulatory Landscape

• Regulatory Framework in the U.S.
• Regulatory Framework in the European Union
• Regulatory Framework in Japan
• Classification and Market Authorization
• Post-Market Surveillance
• Regulatory Framework in India
• Regulatory Framework in China

Chapter 5 Emerging Technologies and Patent Analysis

• Key Takeaways
• Wearable Sleep Tracking Technology
• Sleep Genomics and Pharmacogenomics
• AI-Driven Sleep Analysis
• Neurostimulation Devices
• Cognitive Behavioral Therapy for Insomnia (CBT-I)
• Patent Analysis
• Key Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Sleep Aids Market, by Product Type
• Key Takeaways
• Mattresses and Pillows
• Sleep Apnea Devices
• Medications
• Sleep Laboratories
• Home Sleep Testing (HST)
• Sleep Aids Market, by Sleep Disorder
• Key Takeaways
• Insomnia
• Sleep Apnea
• Restless Legs Syndrome (RLS)
• Others
• Geographic Breakdown
• Sleep Aids Market, by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Industry Scenario
• Opportunity: Emerging Markets
• Key Developments and Strategies
• Partnerships and Collaborations
• Acquisitions
• Business Expansions
• Product Launches and FDA Approvals

Chapter 8 Environmental, Social and Governance Perspective

• Introduction to ESG
• ESG Sustainability in the Sleep Aid Technology Market by Major Manufacturers
• Concluding Remarks from BCC

Chapter 9 Appendix

• Research Methodology
• References
• Abbreviations
• Company Profiles
• ADVANCED BRAIN MONITORING INC.
• ALPHABET INC. (GOOGLE INC.)
• AMBULATORY MONITORING INC.
• AMETRIS LLC.
• APPLE INC.
• APNEA SCIENCES
• BLAIREX LABORATORIES INC.
• CADWELL INDUSTRIES INC.
• CAMNTECH LTD.
• FISHER & PAYKEL HEALTHCARE LTD.
• GSK PLC
• KONINKLIJKE PHILIPS N.V.
• NIHON KOHDEN CORP.
• RESMED
• SANOFI
• Few Emerging Start-ups/Market Disruptors

List of Tables

• Summary Table : Global Market for Sleep Aid, by Region, Through 2030
• Table 1 : NICHD-Funded Research on Sleep
• Table 2 : Porter's Five Forces Analysis: Global Sleep Aid Technology Market
• Table 3 : Estimated Number of Adults with Insomnia and Severe Insomnia Disorders, 2024
• Table 4 : Herbal Supplements for Improving Sleep
• Table 5 : Recall of Sleep Aid Devices, 2023 and 2024
• Table 6 : List of Philips Devices Recalled, by the FDA, 2024
• Table 7 : List of ResMed Inc. Devices Recalled, by FDA, 2024
• Table 8 : Regulatory Requirements in Japan
• Table 9 : Sample Published Patents for Sleep Aid Technology, January 2024-Sept. 2025
• Table 10 : Global Market for Sleep Aid, by Product Type, Through 2030
• Table 11 : Comparison of Selected Innerspring Mattresses
• Table 12 : Comparison of Selected Memory Foam Mattresses
• Table 13 : Comparison of Selected Air Mattresses
• Table 14 : Global Market for Mattresses and Pillows as Sleep Aid, by Region, Through 2030
• Table 15 : Global Market for Sleep Apnea Devices, by Region, Through 2030
• Table 16 : Global Market for Medication as Sleep Aid, by Region, Through 2030
• Table 17 : Global Market for Medication as Sleep Aid, by Type, Through 2030
• Table 18 : Examples of Benzodiazepines
• Table 19 : Pharmacokinetic Profiles of Common Benzodiazepines and Their Approved Indications
• Table 20 : Examples of New Sleeping Pills
• Table 21 : Comparative Efficacies of Selected New Sleeping Pills
• Table 22 : Global Market for Sleep Laboratories, by Region, Through 2030
• Table 23 : Home Sleep Tests vs. Facility-Based Testing
• Table 24 : Global Market for Home Sleep Test Aid, by Region, Through 2030
• Table 25 : Global Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 26 : Mandatory Assessment of Chronic Insomnia
• Table 27 : Physicians' Examinations for the Diagnosis of Chronic Insomnia
• Table 28 : Most Frequently Prescribed Insomnia Drugs
• Table 29 : Global Market for Sleep Aid for Insomnia, by Region, Through 2030
• Table 30 : Global Market for Sleep Aid for Sleep Apnea, by Region, Through 2030
• Table 31 : Global Market for Sleep Aid for Restless Legs Syndrome, by Region, Through 2030
• Table 32 : Prescription Drugs Used for Narcolepsy
• Table 33 : Global Market for Sleep Aid for Other Sleep Disorders, by Region, Through 2030
• Table 34 : Global Market for Sleep Aid, by Region, Through 2030
• Table 35 : North American Market for Sleep Aid, by Product Type, Through 2030
• Table 36 : North American Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 37 : North American Market for Sleep Aid, by Country, Through 2030
• Table 38 : U.S. Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 39 : Canadian Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 40 : Mexican Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 41 : European Market for Sleep Aid, by Product Type, Through 2030
• Table 42 : European Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 43 : European Market for Sleep Aid, by Country, Through 2030
• Table 44 : German Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 45 : U.K. Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 46 : French Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 47 : Italian Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 48 : Spanish Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 49 : Rest of the Europe Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 50 : Asia-Pacific Market for Sleep Aid, by Product Type, Through 2030
• Table 51 : Asia-Pacific Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 52 : Asia-Pacific Market for Sleep Aid, by Country, Through 2030
• Table 53 : Chinese Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 54 : Japanese Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 55 : Indian Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 56 : South Korean Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 57 : Rest of Asia-Pacific Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 58 : South American Market for Sleep Aid, by Product Type, Through 2030
• Table 59 : South American Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 60 : MEA Market for Sleep Aid, by Product Type, Through 2030
• Table 61 : MEA Market for Sleep Aid, by Sleep Disorder, Through 2030
• Table 62 : Leading Manufacturers of Devices and Accessories within the Sleep Aid Technology Market, 2024
• Table 63 : Leading Manufacturers of Pharmaceuticals within the Sleep Aid Technology Market, 2024
• Table 64 : Leading Manufacturers of Diagnostics and Monitoring within the Sleep Aid Technology Market, 2024
• Table 65 : Collaborations and Partnerships: Global Sleep aid technology Market, 2023-2025
• Table 66 : Acquisitions: Global Sleep Aid Technology Market, 2024-2025
• Table 67 : Business Expansion Activities: Global Sleep Aid Technology Market, 2023-2025
• Table 68 : Product Launches and FDA Approval Activities: Global Sleep aid technology Market, 2023-2025
• Table 69 : ESG Highlights, by Major Businesses, 2024
• Table 70 : Information Sources for this Report
• Table 71 : Abbreviations Used in the Sleep Aids Market Report
• Table 72 : Advanced Brain Monitoring Inc.: Company Snapshot
• Table 73 : Advanced Brain Monitoring Inc.: Product Portfolio
• Table 74 : Advanced Brain Monitoring Inc.: News/Key Developments, 2024-2025
• Table 75 : Alphabet Inc. (Google Inc.): Company Snapshot
• Table 76 : Alphabet Inc. (Google Inc.): Financial Performance, FY 2023 and 2024
• Table 77 : Alphabet Inc. (Google Inc.): Product Portfolio
• Table 78 : Alphabet Inc. (Google Inc.): News/Key Developments, 2023-2025
• Table 79 : Ambulatory Monitoring Inc.: Company Snapshot
• Table 80 : Ambulatory Monitoring Inc.: Product Portfolio
• Table 81 : Ambulatory Monitoring Inc.: News/Key Developments, 2025
• Table 82 : Ametris LLC.: Company Snapshot
• Table 83 : Ametris LLC.: Product Portfolio
• Table 84 : Ametris LLC.: News/Key Developments, 2024-2025
• Table 85 : Apple Inc.: Company Snapshot
• Table 86 : Apple Inc.: Financial Performance, FY 2024 and 2025
• Table 87 : Apple Inc.: Product Portfolio
• Table 88 : Apple Inc.: News/Key Developments, 2024-2025
• Table 89 : Apnea Sciences: Company Snapshot
• Table 90 : Apnea Sciences: Product Portfolio
• Table 91 : Apnea Sciences: News/Key Developments, 2023-2024
• Table 92 : Blairex Laboratories Inc.: Company Snapshot
• Table 93 : Blairex Laboratories Inc.: Product Portfolio
• Table 94 : Cadwell Industries Inc.: Company Snapshot
• Table 95 : Cadwell Industries Inc.: Product Portfolio
• Table 96 : Cadwell Industries Inc.: News/Key Developments, 2025
• Table 97 : CamNtech Ltd.: Company Snapshot
• Table 98 : CamNtech Ltd.: Product Portfolio
• Table 99 : CamNtech Ltd.: News/Key Developments, 2023
• Table 100 : Fisher & Paykel Healthcare Ltd.: Company Snapshot
• Table 101 : Fisher & Paykel Healthcare Ltd.: Financial Performance, FY 2023 and 2024
• Table 102 : Fisher & Paykel Healthcare Ltd.: Product Portfolio
• Table 103 : Fisher & Paykel Healthcare Ltd.: News/Key Developments, 2023-2025
• Table 104 : GSK plc: Company Snapshot
• Table 105 : GSK plc: Financial Performance, FY 2023 and 2024
• Table 106 : GSK plc: Product Portfolio
• Table 107 : GSK plc: News/Key Developments, 2024
• Table 108 : Koninklijke Philips N.V.: Company Snapshot
• Table 109 : Koninklijke Philips N.V.: Financial Performance, FY 2023 and 2024
• Table 110 : Koninklijke Philips N.V.: Product Portfolio
• Table 111 : Koninklijke Philips N.V.: News/Key Developments, 2023-2025
• Table 112 : Nihon Kohden Corp.: Company Snapshot
• Table 113 : Nihon Kohden Corp.: Financial Performance, FY 2023 and 2024
• Table 114 : Nihon Kohden Corp.: Product Portfolio
• Table 115 : Nihon Kohden Corp.: News/Key Developments, 2023-2025
• Table 116 : ResMed: Company Snapshot
• Table 117 : ResMed: Financial Performance, FY 2023 and 2024
• Table 118 : ResMed: Product Portfolio
• Table 119 : ResMed: News/Key Developments, 2022-2025
• Table 120 : Sanofi: Company Snapshot
• Table 121 : Sanofi: Financial Performance, FY 2023 and 2024
• Table 122 : Sanofi: Product Portfolio
• Table 123 : Sanofi: News/Key Developments, 2024-2025
• Table 124 : List of a Few Emerging Startups/Market Disruptors

List of Figures

• Summary Figure : Global Market Shares for Sleep Aid, by Region, 2024
• Figure 1 : Market Dynamics of Sleep Aid Technologies
• Figure 2 : ResMed Sleep Survey, 2024
• Figure 3 : Number of Patents Documented on Sleep Aid Technology, by Leading Companies, January 2023-Sept. 2025
• Figure 4 : Patent Shares for Sleep Aid Technology, by Jurisdiction, January 2023-Sept. 2025
• Figure 5 : Patents Shares for Sleep Aid Technology, by Type, January 2023-Sept. 2025
• Figure 6 : Global Market Shares for Sleep Aid, by Product, 2024
• Figure 7 : Global Market Shares for Medication as Sleep Aid, by Product Type, 2024
• Figure 8 : Global Market Shares for Sleep Aid, by Sleep Disorder, 2024
• Figure 9 : Global Market Shares for Sleep Aid, by Region, 2024
• Figure 10 : Alphabet Inc. (Google Inc.): Revenue Share, by Business Unit, FY 2024
• Figure 11 : Alphabet Inc. (Google Inc.): Revenue Share, by Country/Region, FY 2024
• Figure 12 : Apple Inc.: Revenue Share, by Business Unit, FY 2025
• Figure 13 : Apple Inc.: Revenue Share, by Country/Region, FY 2025
• Figure 14 : Fisher & Paykel Healthcare Ltd.: Revenue Share, by Business Unit, FY 2024
• Figure 15 : Fisher & Paykel Healthcare Ltd.: Revenue Share, by Country/Region, FY 2024
• Figure 16 : GSK plc: Revenue Share, by Business Unit, FY 2024
• Figure 17 : GSK plc: Revenue Share, by Country/Region, FY 2024
• Figure 18 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2024
• Figure 19 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2024
• Figure 20 : Nihon Kohden Corp.: Revenue Share, by Business Unit, FY 2024
• Figure 21 : Nihon Kohden Corp.: Revenue Share, by Country/Region, FY 2024
• Figure 22 : ResMed: Revenue Share, by Business Unit, FY 2024
• Figure 23 : ResMed: Revenue Share, by Country/Region, FY 2024
• Figure 24 : Sanofi: Revenue Share, by Country/Region, FY 2024